Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
619.73B
Market cap619.73B
Price-Earnings ratio
30.41
Price-Earnings ratio30.41
Dividend yield
1.99%
Dividend yield1.99%
Average volume
10.55M
Average volume10.55M
High today
$261.50
High today$261.50
Low today
$255.93
Low today$255.93
Open price
$260.76
Open price$260.76
Volume
2.21M
Volume2.21M
52 Week high
$263.10
52 Week high$263.10
52 Week low
$154.21
52 Week low$154.21

Stock Snapshot

With a market cap of 619.73B, Johnson & Johnson(JNJ) trades at $257.45. The stock has a price-to-earnings ratio of 30.41 and currently yields dividends of 1.99%.

As of 2026-07-06, Johnson & Johnson(JNJ) stock has fluctuated between $255.93 and $261.50. The current price stands at $257.45, placing the stock +0.6% above today's low and -1.6% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 2.21M, compared to an average daily volume of 10.55M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $263.10 and a 52-week low of $154.21.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $263.10 and a 52-week low of $154.21.

JNJ News

Investor's Business Daily 39m
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings

IBD Stock Of The Day Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings Licensing Johnson & Johnson Johnson & Johnson JNJ $ 256.74 $6.30...

Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into Earnings
TipRanks 2h
Johnson & Johnson price target raised to $290 from $280 at HSBC

HSBC raised the firm’s price target on Johnson & Johnson to $290 from $280 and keeps a Buy rating on the shares. In a sector note on Healthcare, HSBC adjusted t...

Zacks 2h
J&J's MedTech Segment Eyes Another Strong Quarter in Q2 - Zacks Investment Research

...

J&J's MedTech Segment Eyes Another Strong Quarter in Q2 - Zacks Investment Research

Analyst ratings

69%

of 26 ratings
Buy
69.2%
Hold
26.9%
Sell
3.8%

More JNJ News

Benzinga 5h
Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson (NYSE:JNJ) will release its second quarter earnings report before the opening bell on Wednesday, July 15. Analysts expect the New Brunswick,...

Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
24/7 Wall St. 1d
How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields

How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields By Drew Wood Published Jul 5, 9:52AM EDT Quick Read Generating $500 a month from di...

How To Turn A Portfolio Into $500 A Month Without Chasing Dangerous Yields
Simply Wall St 1d
Johnson & Johnson Stock Looks Undervalued On Cash Flow While Earnings Look Fair

Johnson & Johnson stock has delivered a strong 80.3% return over the last three years, yet the valuation checks send a mixed message, with the Discounted Cash F...

Johnson & Johnson Stock Looks Undervalued On Cash Flow While Earnings Look Fair
24/7 Wall St. 2d
The Portfolio That Lets You Go Part-Time Five Years Early

The Portfolio That Lets You Go Part-Time Five Years Early By Drew Wood Published Jul 4, 3:11PM EDT Quick Read Replacing $40,000 in lost income requires betwee...

The Portfolio That Lets You Go Part-Time Five Years Early
24/7 Wall St. 2d
What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality By Drew Wood Published Jul 4, 1:09PM EDT Quick Read A $750,000 po...

What A $750,000 Dividend Portfolio Actually Pays After Taxes, Medicare Premiums, And Reality
Nasdaq 3d
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

Key Points Johnson & Johnson's CEO recently explained that his company isn't going to get caught up in the GLP-1 weight loss drug race. Instead, the company w...

Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?
24/7 Wall St. 3d
The Portfolio That Pays For Season Tickets Forever

The Portfolio That Pays For Season Tickets Forever By Drew Wood Published Jul 3, 7:01AM EDT Quick Read Dividing your annual ticket cost by a portfolio yield s...

The Portfolio That Pays For Season Tickets Forever

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.